20/20 Biolabs, Inc. (AIDX)
NASDAQ · Healthcare
20/20 Biolabs, Inc. Gross Profit 2024–2025
20/20 Biolabs, Inc. annual/quarterly gross profit history and growth rate from 2024 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- 20/20 Biolabs, Inc. gross profit for the quarter ending March 31, 2026 was 62884, a 62.07% decrease year-over-year.
- 20/20 Biolabs, Inc. annual gross profit for 2025 was 604541, a 67.78% increase from 2024.
- 20/20 Biolabs, Inc. annual gross profit for 2024 was 360311.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
20/20 Biolabs, Inc. Gross Profit — FAQ
20/20 Biolabs, Inc. (AIDX) gross profit over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is 20/20 Biolabs, Inc.'s gross profit?
20/20 Biolabs, Inc. (AIDX) reported gross profit of $604,541 for fiscal 2025.
Where can I see AIDX's gross profit history?
The chart and table above show 20/20 Biolabs, Inc.'s gross profit by year and by quarter, including the growth rate.